Abstract: China’s first regulatory document dedicated to the management of cosmetic adverse reaction monitoring, “the Measures for the Management of Cosmetic Adverse Reaction Monitoring” was released, which requires cosmetic registrants and filers to monitor the adverse reactions of their cosmetics on the market and conduct timely evaluations.
